Form 4 for DGX Quest Diagnostics
Accepted 2024-12-02 00:00:00 ET · period of report 2024-11-27 · accession 0001022079-24-000206 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-02 | 2024-11-27 | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale+OE | $162.99 | -33.1K | 96.7K | -26% | -$5.40M |
| D | 2024-12-02 | 2024-11-27 | DGX | Doherty Catherine T. | EVP, Regional Businesses | M - OptEx | $103.57 | +33.1K | 101.5K | +48% | +$3.43M |
| D | 2024-12-02 | 2024-11-27 | DGX | Doherty Catherine T. | EVP, Regional Businesses | M - OptEx | $103.57 | -33.1K | 0 | -100% | -$3.43M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-27 | S | D | 28,300 | $163.13 | 68,412 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $162.815 to $163.790. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-11-27 | S | D | 4,803 | $162.14 | 96,712 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $161.790 to $162.785. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2024-11-27 | M | A | 33,103 | $103.57 | 101,515 | D | — | — | |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2024-11-27 | M | D | 33,103 | $103.57 | 0 | D | $103.57 · — to 2028-02-19 | 33,103 Common Stock | (F5) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |